Medicinal Products

Pradaxa

Name Pradaxa
Active Substance dabigatran etexilate mesilate
Prescription na recept
Type of prescription ponovljivi recept
Distribution u ljekarni
ATC Code B01AE07
Medicinal product marketed in the Croatia Da
Educational materials
for healthcare professionals
Vodič za propisivače pVTEp, verzija 4
Vodič za propisivače SPAF, verzija 4
Educational materials
for patients / caregivers
Kartica s upozorenjima za bolesnika, siječanj 2018

Note

The medicinal product has been authorised via centralised procedure in all Member States of the European Union based on the European Medicines Agency's expert opinion. Additional information on the medicinal product can be found under the following link:https://www.ema.europa.eu/en/medicines/human/EPAR/pradaxa

The marketing authorisation has been granted by the European Commission. All marketing authorisations of the European Commission can be found under the following link: http://ec.europa.eu/health/documents/community-register/html/index_en.htm

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o mogućem povećanom riziku od ponavljajućih trombotskih događaja u bolesnika s antifosfolipidnim sindromom na terapiji direktnim oralnim antikoagulansom 22.05.2019 Bayer AG, Daiichi Sankyo Europe GmbH, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb/Pfizer EEIG
Back